Production of recombinant PvDBPII, receptor binding domain of Plasmodium vivax Duffy binding protein, and evaluation of immunogenicity to identify an adjuvant formulation for vaccine development-Reference-Cited by-同舟云学术

Production of recombinant PvDBPII, receptor binding domain of Plasmodium vivax Duffy binding protein, and evaluation of immunogenicity to identify an adjuvant formulation for vaccine development

Published:2017-08 Issue: Volume:136 Page:52-57
ISSN:1046-5928
Container-title:Protein Expression and Purification
language:en
Short-container-title:Protein Expression and Purification

Author:

Bhardwaj Rukmini,Shakri Ahmad Rushdi,Hans Dhiraj,Gupta Pankaj,Fernandez-Becerra Carmen,del Portillo Hernando A.,Pandey Gaurav^ORCID,Chitnis Chetan E.

Funder

PATH

Government of India

Publisher

Elsevier BV

Subject

Biotechnology

Reference10 articles.

1. The international limits and population at risk of Plasmodium vivax transmission in 2009;Guerra;PLoS negl. Trop. Dis.,2010

2. The resistance factor to Plasmodium vivax in blacks. The Duffy-blood-group genotype, FyFy;Miller;N. Engl. J. Med.,1976

3. Identification of the erythrocyte binding domains of Plasmodium vivax and Plasmodium knowlesi proteins involved in erythrocyte invasion;Chitnis;J. Exp. Med.,1994

4. Evaluation of immune responses elicited in mice against a recombinant malaria vaccine based on Plasmodium vivax Duffy binding protein;Yazdani;Vaccine,2004

5. Naturally acquired Duffy-binding protein-specific binding inhibitory antibodies confer protection from blood-stage Plasmodium vivax infection;King;Proc. Natl. Acad. Sci. U. S. A.,2008

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PvDBPII elicits multiple antibody-mediated mechanisms that reduce growth in a Plasmodium vivax challenge trial;npj Vaccines;2024-01-06

2. Preliminary characterization of Plasmodium vivax sporozoite antigens as pre-erythrocytic vaccine candidates;PLOS Neglected Tropical Diseases;2023-09-13

3. Immunogenicity of a Plasmodium vivax vaccine based on the duffy binding protein formulated using adjuvants compatible for use in humans;Scientific Reports;2023-08-25

4. PvDBPII-Matrix M elicits polyfunctional antibodies that limit parasite growth in a challenge trial;2023-08-02

5. Cysteine Residues in Region 6 of the Plasmodium yoelii Erythrocyte-Binding-like Ligand That Are Related to Its Localization and the Course of Infection;Biomolecules;2023-03-02